Evidence map›Paper›PMID 42255816›Full record

ArticleCureus2026

Inpatient Stress Test Modality and Downstream Clinical Pathways in Troponin-Negative Patients: A Real-World Cohort Study.

Admire Hlupeni, Sudden Turugari, Jeffrey Murray

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Admire HlupeniImmunology, Midlands State University, Gweru, ZWE.
Sudden TurugariInternal Medicine, Midlands State University, Gweru, ZWE.
Jeffrey MurrayCardiology, St. Luke's Hospital, Chesterfield, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Troponin-negative patients presenting with suspected acute coronary syndrome are frequently admitted for inpatient stress testing. The relative yield of different stress test modalities and their influence on downstream clinical decision-making in this population remain uncertain. Methods We conducted a retrospective cohort study of 769 consecutive troponin-negative adult patients (≥18 years) undergoing inpatient stress testing at St Luke's, a community teaching hospital in the Midwest, USA. Stress test modalities were categorized as nuclear myocardial perfusion imaging (MPI), stress echocardiography, or exercise electrocardiography (ECG)-only. The primary outcome was stress test positivity defined as the presence of inducible ischemia as interpreted by the reading cardiologist. This included reversible perfusion defects on nuclear MPI, inducible regional wall motion abnormalities on stress echocardiography, or ischemic ECG changes during exercise testing. Secondary outcomes included referral to invasive coronary angiography (ICA), detection of obstructive coronary artery disease (CAD), and subsequent revascularization. Multivariable Poisson regression models with robust standard errors were used to evaluate the association between stress test modality and outcomes after adjustment for baseline characteristics. Results Nuclear MPI was the most commonly conducted modality (n=616, 80.1%), followed by stress echocardiography (n=144, 18.7%) and exercise ECG-only testing (n=9, 1.2%). Comparisons were performed between nuclear MPI and stress echocardiography, as the ECG-only subgroup was small. Stress test positivity rates were similar between nuclear MPI and stress echocardiography (n=60, 9.7% vs n=12, 8.3%, p=0.80). No positive tests were observed in the ECG-only group, though this subgroup was very small. Referral to ICA was primarily driven by stress test results rather than modality. Among patients with positive stress tests, ICA was performed in 80% (48/60) of nuclear MPI and 75% (9/12) of stress echocardiography cases (p=0.71), whereas ICA was infrequently performed following negative tests (5.8% (32/556) vs 2.3% (3/132), respectively; p=0.23). Overall, ICA utilization did not differ significantly between nuclear MPI (n=80, 13.0%) and stress echocardiography (n=12, 8.3%), p=0.21. Among patients undergoing ICA, rates of obstructive CAD (37.5% (30/80) vs 41.7% (5/12), p=0.76) and revascularization (32.5% (26/80) vs 41.7% (5/12), p=0.53) were also similar between nuclear MPI and stress echocardiography groups, respectively. In adjusted analyses, stress test modality was not independently associated with stress test positivity (adjusted risk ratio 0.97, 95% CI 0.51-1.85; p=0.94) or referral to ICA (adjusted risk ratio 0.61, 95% CI 0.32-1.14; p=0.12). Conclusions In this single-center retrospective cohort, both unadjusted and adjusted analyses demonstrated similar stress test yield and downstream referral to ICA between nuclear MPI and stress echocardiography. These findings suggest that, in this setting, stress test modality may have limited influence on clinical decision-making following negative troponin evaluation. Despite consistent findings after adjustment, residual confounding cannot be excluded; therefore, these results should be interpreted as observational associations rather than evidence of causal effects.

Indexed as

clinical pathwayscoronary artery diseaseinvasive coronary angiographymyocardial perfusion imagingstress echocardiographystress testingtroponin-negative

Identifiers

PMID42255816
PMCPMC13242261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.